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Transfection of human papillomavirus (HPV) 16 E6 oncogene into foreskin primary human keratinocytes (PHKs) causes the
formation of colonies of viable cells resistant to serum–calcium differentiation. To define the stage of keratinocyte
differentiation inhibited by E6, we examined the response of PHKs to serum and calcium with respect to parameters of both
growth and differentiation. The effect of HPV16 E6 was evaluated by infection with recombinant retroviruses encoding the
E6 protein. Results of these studies indicated that terminal differentiation of cultured foreskin keratinocytes, triggered by
serum and calcium, is a progressive process (2–3 weeks) that ends with cell death with characteristics of apoptosis. Human
keratinocyte terminal differentiation was accompanied by time-related changes in the expression of cellular proteins involved
in the control pathways of apoptosis, including downregulation of Bcl-2 and p53 and upregulation of Bax, which coincided
with the appearance of morphological signs of apoptosis. E6 expression did not override the differentiation-associated G1
arrest or prevent the induction of squamous differentiation-specific markers, transglutaminase 1 and involucrin. E6 expres-
sion led, however, to a significant reduction in cell stratification and cell death by apoptosis, which correlated with prolonged
expression of Bcl-2 and reduced elevation of Bax levels that occurred concomitant with a complete loss of p53. The data
argue that E6 inhibits terminal differentiation of foreskin PHKs through inhibition of their differentiation-induced apoptotic
program. © 1999 Academic PressW
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Infection of the anogenital mucosa with papillomavirus
ypes referred to as “high risk” or “oncogenic” is a major
actor for the subsequent development of cancer. Human
apillomavirus (HPV) 16 is the most common type de-
ected in human cervical dysplasia and carcinoma (re-
iewed by Zur-Hausen, 1996). HPV infection of the basal
pithelium perturbs cell differentiation and enhances cell
roliferation. Two oncoproteins are encoded by the on-
ogenic HPVs, E6 and E7. The ability of these viral pro-
eins to form complexes with cellular regulatory proteins
nd inactivate their function has been suggested as a
echanism by which HPVs interfere with the control of
ell growth and proliferation (reviewed by Vousden 1994,
995).
Squamous epithelial cells are the natural host cells for
PV infection and in vitro cultured genital human kera-
inocytes have been used to study the consequences of
PV E6 and E7 expression. These studies showed that
6 and E7 proteins cooperate to immortalize primary
uman keratinocytes (PHKs) (Schlegel et al., 1988; Haw-
ey-Nelson et al., 1989), alter the differentiated phenotype
f keratinocytes (Hudson et al., 1990; Halbert et al., 1992;
1 These authors contributed equally to this study.
2 To whom correspondence and reprint requests should be ad-
ressed. Fax: 972-3-6409160. E-mail: Isherman@post.tau.ac.il.383oodworth et al., 1992), and inhibit keratinocyte terminal
ifferentiation induced by serum and calcium (Schlegel
t al., 1988; Munger et al., 1989). The roles of the indi-
idual viral genes in altering epidermal differentiation
nd mechanisms of activity are not completely under-
tood.
The process of keratinocyte differentiation in vivo is
ighly regulated (reviewed by Watt, 1989; Fuchs and
yrne, 1994; Fuchs, 1995). As cells move from the
asal layer, they cease proliferation to produce dis-
inctive keratins and differentiation-specific proteins.
n the uppermost layer of the epidermis the cell struc-
ures are destroyed and the accumulated fiber pro-
eins are cross-linked to form the cornified layer. This
ell death process shares several properties with pro-
rammed cell death (PCD), such as the destruction of
ell nuclei and the induction of cross-linking transglu-
aminases (Polakowska et al., 1994). In the raft culture
ystem, as a model for reproducing the three-
imensional structure of the skin, expression of E7
lone had a limited effect on morphological differen-
iation (Hudson et al., 1990; Blanton et al., 1992; Cheng
t al., 1995), although E7, but not E6, was capable of
eactivating cellular DNA synthesis in the suprabasal
ifferentiated keratinocytes (Blanton et al., 1992; Hal-
ert et al., 1992; Cheng et al., 1995) and overcoming
uprabasal cell quiescence (Demers et al., 1996; Jian0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
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384 ALFANDARI ET AL.t al., 1998). Using serum–calcium to induce terminal
ifferentiation of PHK, HPV16 E7 was shown to delay
he rate of induction of differentiation markers and to
vercome p21/Cip1-mediated inhibition of Cdk2 activ-
ty during differentiation, thereby apparently contribut-
ng to the ability of E7 to allow for cellular DNA syn-
hesis in differentiated keratinocytes (Jones et al.,
997). Using a quantitative keratinocyte assay that
cores for proliferation resistance to serum and cal-
ium differentiation, we showed that HPV16 E6 protein
y itself, but not E7 protein, was capable of inducing
olonies of live cells to become resistant to terminal
ifferentiation (Sherman and Schlegel, 1996; Sherman
t al., 1997). Differentiation resistance induced by E6
rotein was found to be separable from cellular im-
ortalization, which required the combined presence
f E7 protein. Terminal differentiation of cultured epi-
ermal keratinocytes triggered by serum and calcium,
lthough unable to reproduce the layer organization of
he skin, mimics many of the morphological and bio-
hemical changes occurring during keratinocyte dif-
erentiation in vivo, including cessation of cell division,
roduction of proteins specifically associated with the
rocess of keratinization, and ultimately cell death
Hennings et al., 1980; Boyce and Ham, 1983; Pittelkow
t al., 1986; Schlegel et al., 1988). Colony formation by
6 could result from inhibition of any of these events.
o gain knowledge on the metabolic pathway per-
urbed by E6 we further investigated the response of
uman foreskin keratinocytes to serum and calcium
ith respect to the parameters of growth and differen-
iation. The effect of E6 was evaluated by infection of
HKs with retroviral vectors carrying an epitope-
agged HPV16 E6 or vector DNA prior to the induction
f differentiation.
Results of this study further showed that cultured
HKs respond to serum–calcium with the induction of
rogressive changes in cell growth, morphology, and
iochemistry that develop during 2–3 weeks of mainte-
ance in differentiation medium. The end process of
eratinocyte differentiation is cell death with character-
stics of apoptosis. The process of terminal differentia-
ion was associated with changes in the expression of
roteins controlling growth and programmed cell death,
ncluding a decrease in p53 and Bcl-2 protein levels and
n increase in the level of Bax that coincided with the
nduction of apoptosis. E6 expression did not prevent the
ifferentiation-imposed cell cycle withdrawal and the in-
uction of squamous differentiation marker proteins, in-
olucrin and transglutaminase 1. E6 markedly reduced
ell stratification and cell death by apoptosis, which
orrelated with prolonged expression of Bcl-2 and sig-
ificantly reduced elevation of Bax levels. The data sug-
est that E6 acts to extend the survival of terminally
ifferentiated keratinocytes by inhibition of their apopto-
ic cell death.RESULTS
PV16 E6 does not prevent the expression of
ifferentiation-specific proteins
Growth of human and mouse epidermal keratinocytes
n serum-free medium containing low levels of calcium
esembles that of basal keratinocytes. Increasing the
evels of calcium and serum induces their terminal dif-
erentiation (Hennings et al., 1980; Boyce and Ham, 1983;
chlegel et al., 1988). To define the stage of keratinocyte
ifferentiation inhibited by E6 (Sherman and Schlegel,
996) we first delineated the changes in cell growth and
iochemistry occurring during keratinocyte differentia-
ion in vitro and their time correlation. PHKs were grown
n keratinocyte serum-free growth medium (KSFM) to
each 80–90% confluency and subsequently switched to
ifferentiation medium consisting of Dulbecco’s modified
agle’s medium (DMEM) with 2 mM calcium, 10% fetal
alf serum, and 1 mg/ml hydrocortisone as previously
escribed (Schlegel et al., 1988). Cells were maintained
n differentiation medium for 3–4 weeks. Western blot
nalyses of extracts of cells before and at different in-
ervals (4 days to 3 weeks) after serum–calcium switch
Fig. 1) indicated the activation of differentiation-specific
arkers, type 1 transglutaminase (Tgs) and involucrin,
he most abundant precursor of the cornified envelope,
oth hallmarks of squamous epithelial differentiation (re-
iewed by Watt, 1989). Protein levels increased progres-
ively and reached maximal levels at weeks 1 or 2
ubsequent to the switch and then progressively de-
reased. Levels of Tgs peaked earlier than that of involu-
rin. Unexpectedly, keratin 19 (CK 19), which has a wide-
pread distribution pattern in both simple and stratifying
pithelia (Moll et al., 1982; Quinlain et al., 1995) and
hich has been shown to be expressed at high levels in
PV immortalized keratinocytes (Pirisi et al., 1988; Wood-
orth et al., 1988), was upregulated in response to se-
um–calcium switch, reaching maximal levels in the sec-
nd week of growth in differentiation medium and then
ecreased (Fig. 1). Protein expression of cytokeratin 19
nd involucrin was also induced upon an increase in cell
onfluency, as observed in cells grown in KSFM to 90%
0) versus 50% (09) confluency, before serum–calcium
witch (Fig. 1). The ability of E6 to alter the differentiation
rogram of PHKs was assessed by comparing the tem-
oral expression of the differentiation-specific markers
escribed above between PHKs infected with a LXSN-
ased retrovirus vector carrying the epitope-tagged
PV16 E6 (E6A) (Pei et al., 1998; Shnitman Magal et al.,
998) and matched controls infected with the parental
XSN virus. Expression of the markers was monitored at
ifferent time intervals during 3 weeks subsequent to
erum–calcium switch (Fig. 2).
Patterns of expression of the respective markers in the
ector infected cultures were comparable to that ob-
erved in uninfected keratinocytes (Fig. 1), showing pro-
ressive increase during the first (Tgs and involucrin)
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385HPV16 E6 ONCOPROTEIN INHIBITS APOPTOSISnd second weeks (CK19) followed by a decrease. Ex-
ression patterns of the differentiation markers in the
6A virus infected cultures were similar although some-
hat retarded. The time points reaching maximal levels
f protein expression as well as the subsequent drops
ollowed that of the vector cultures. This delay in peak
xpression in E6A virus infected cultures was observed
n additional experiments in which involucrin expression
as analyzed by Western blot and fluorescence staining
data not shown), suggesting that E6 may delay upregu-
ation of differentiation marker proteins.
6 reduces cell death–apoptosis associated with
erminal differentiation of primary human
eratinocytes
Subsequent to serum–calcium switch PHK cultures
howed morphological changes characteristic of dif-
erentiating keratinocytes including flattening and en-
argement of cells followed by cell stratification, which
as most pronounced at weeks 2 and 3, and finally
ell detachment. The upper layers of the stratifying
ells contained cells with keratin bundles and con-
ensed nuclei (Fig. 3). Immunofluorescence staining
f PHKs grown for 3 weeks in differentiation medium
ith a monoclonal antibody to involucrin showed high
ytoplasmic and membranal staining in the stratifying
FIG. 1. Time-related changes in the expression of differentiation-spe
rotein of cell lysates was fractionated on 12% polyacrylamide–SDS ge
ith antibodies to the indicated proteins (A). Levels of the proteins, queratinocytes (data not shown). Terminally differenti-
ting keratinocytes present in the uppermost layers
nd in supernatants presented morphological charac-
eristics of apoptotic cells including condensed chro-
atin and fragmented DNA, which stained positive by
n situ detection of DNA breaks (terminal deoxy trans-
erase-mediated dUTP biotin nick end-labeling,
UNEL) (Gavrieli et al., 1992), nuclear fragmentation,
nd formation of apoptotic bodies (Figs. 3 and 4). The
atter features were mainly observed in the detached
ells (Fig. 4B).
We showed previously that transfection of plasmids
arrying the wild-type or epitope-tagged E6 gene linked
o the early SV40 promoter into PHKs caused the forma-
ion of colonies of viable cells resistant to serum–
alcium-induced terminal differentiation (Sherman and
chlegel, 1996). 49,6-Diamidine-2-phenylindole-dihydro-
hloride (DAPI) stain of cultures transfected with the E6A
xpression plasmid revealed the presence of apoptotic
ells in the stratifying layers of terminally differentiating
eratinocytes that surround the E6-induced colony re-
ion. The cells in the colony contained nuclei with nor-
al appearance (data not shown). This observation
aised the possibility that colony formation by E6 resulted
rom the ability of E6A to suppress apoptosis. To further
onfirm the ability of E6 to inhibit apoptosis and quanti-
roteins following serum–calcium switch. One hundred micrograms of
transferred to a nitrocellulose membrane. Strips were cut and probed
by densitometric scanning, are shown in B.cific p
ls and
antified
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386 ALFANDARI ET AL.ate the effect, keratinocytes infected with the vector or
6A virus, after being selected in G418, were seeded into
ell chambers to form monolayers at 24 h. Medium was
hen changed to differentiation medium and chambers
ere monitored for apoptosis by DAPI and TUNEL stain,
t various time points after the switch. Figure 5A shows
ime-correlated morphological changes in nuclei of cells
tained with DAPI. Figure 5B shows the proportion of
poptotic nuclei in E6A and vector infected cultures.
poptotic cells were occasionally observed in keratino-
yte monolayers before and during the first week after
erum–calcium switch, both in E6A and in vector virus
nfected cultures. As demonstrated for uninfected cul-
ures (Figs. 3 and 4), cell stratification and morphological
hanges characteristic of apoptosis started to appear in
he vector virus infected cultures after 2 weeks of growth
n differentiation medium and were mostly pronounced at
ay 22. Apoptotic nuclei were present mainly in the
tratifying layers. Cells infected with the E6A virus
howed marked reduction in both cell stratification and
poptosis.
6 expression does not prevent growth arrest
nduced by serum–calcium
The process of differentiation of epidermal keratino-
ytes in response to serum–calcium is accompanied by
FIG. 2. Time-related changes in the expression of differentiation-spec
lot analyses of lysates of cells infected with the vector or E6A carryin
canning are shown in B.essation of cell proliferation. Previous studies have
hown that HPV16 E6 was capable of overriding growth
rrest signals induced by DNA damaging agents and
hat this effect was linked to the elimination of p53
rotein (Foster et al., 1994). To examine the effect of E6A
n cell growth and arrest induced by serum–calcium,
ACS analyses of cells stained with propidium iodine
ere carried out before and at different time intervals
fter serum–calcium switch (3–18 days). Table 1 summa-
izes the results obtained from two independent experi-
ents (Experiments 1 and 2). The cell cycle profiles of
xperiment 1 are shown in Fig. 6. Cultures infected with
he vector or E6A virus showed comparable changes in
he distribution of cells in the cell cycle phases. A grad-
al increase in the proportion of cells present in G1
hase, concomitant with a decrease in the proportion of
ells present in S phase, was observed in both virus
nfected cultures with about 80% of the cells accumulat-
ng in G1 at day 18 subsequent to serum–calcium switch.
ACS analyses revealed also that cells containing a low
ontent of DNA (sub-G1), characteristic of apoptotic cells,
ppeared after 2 weeks of selection in differentiation
edium and were present only in the vector cultures.
hese results further indicated that E6 inhibited the in-
uction of apoptosis in terminally differentiated keratino-
ytes. The percentage of apoptotic cells in the vector
teins in virally infected PHKs, following serum–calcium switch. Western
es are shown in A. Levels of the proteins quantified by densitometricific pro
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387HPV16 E6 ONCOPROTEIN INHIBITS APOPTOSISirus infected cultures, determined by counting of
tained nuclei (Fig. 5B), was higher than the percentage
f cells with low-content DNA, detected in the sub-G1
eaks (13.6 6 8.9) in three independent experiments
Table 1; and data not shown). This difference may be
ue to the analysis of the FACS data with the MULTY-
YCLE program (Phoenix Flow Systems), which would
easure only a subpopulation of apoptotic cells. This
opulation could not include cell aggregates and dis-
upted cells though such cells may have been stained
nd counted as apoptotic by direct stain of the culture.
6 modulates the expression of apoptosis-associated
roteins p53, Bcl-2, and Bax
To understand the relationship between the keratino-
yte differentiation program and the induction of cell
eath, the temporal expression of growth-/apoptosis-
ssociated proteins was examined in differentiating ker-
tinocytes (Fig. 7). p53, a major regulator of cell growth
nd apoptosis (reviewed by Levine, 1997), was down-
egulated upon serum–calcium switch, reaching its low-
st levels (fourfold reduction) at days 14 and 23, in
greement with previous studies that have shown down-
egulation of p53 upon induction of differentiation in
FIG. 3. Microscopic appearance of primary human keratinocytes bef
). Phase-contrast photographs are shown in a and c. Fluorescence m
tratification, keratin bundles, and condensed highly stained nuclei arouse keratinocytes by high calcium levels (Missero et
l., 1995) or in human keratinocytes grown on collagen
afts (Woodworth et al., 1993).
An important class of molecules that regulate PCD is
he Bcl-2 family (reviewed by Yang and Korsmeyer, 1996;
elekar and Thompson, 1998). Members of the family
ave been shown to either suppress (Bcl-2, Bcl-Xl) or
romote (Bax, Bcl-Xs, Bad, and Bak) apoptosis. In squa-
ous epithelium, Bcl-2 was shown to be expressed
xclusively in the undifferentiated basal layer (Hocken-
ery et al., 1991; Lu et al., 1993; Polakowska et al., 1994;
ordan et al., 1996), while expression of Bax was found to
e more pronounced in suprabasal cells (Jordan et al.,
996; Maruoka et al., 1997).
Upon serum–calcium switch, an inverse relationship
etween the expression of Bcl-2 and Bax was observed
Fig. 7). Levels of Bcl-2, a survival protein and negative
egulator of apoptosis, decreased rapidly and became
lmost undetectable after 4 days (12- to 15-fold decrease
easured at day 23 relative to 09 and 0 time cultures,
espectively) while levels of Bax, a proapoptotic protein,
ncreased progressively, reaching maximal levels during
he second week (3- to 4-fold increase measured at day
4 relative to 0 and 09 time cultures, respectively) when
and b) and after 3 weeks of selection in differentiation medium (c and
pe photographs of cells stained with DAPI are shown in b and d. Cell
ved in the differentiated cultures (c and d).ore (a
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388 ALFANDARI ET AL.poptosis, as defined by morphological criteria, com-
enced.
To gain knowledge on the growth/apoptosis pathways
erturbed by E6, we compared the time pattern of
hanges in the expression of p53, Bcl-2, and Bax subse-
uent to serum–calcium switch between vector and E6A
nfected cultures (Fig. 8). Immunoblot analyses of ex-
racts obtained from two independent experiments are
hown in Figs. 8A, 8B, and 8C, respectively. The levels
nd time patterns of changes in the expression of p53,
cl-2, and Bax in the vector cultures were similar to
hose observed in uninfected keratinocytes (Fig. 7).
FIG. 4. Apoptosis in terminally differentiating keratinocytes. Monolay
edium is shown in A. Most of the nuclei exhibiting apoptotic features b
etached cells collected from supernatants, exhibiting nuclear fragmehese included a progressive decrease of p53, reaching
he lowest levels at weeks 2 and 3, a rapid decrease of
cl-2 (in the first week), and a subsequent increase in
ax with peak expression at weeks 2–3. In keratinocytes
nfected with the E6A virus, p53 rapidly disappeared and
as almost undetectable subsequent to serum–calcium
witch. This was most likely due to the E6A-induced
egradation of p53 through the ubiquitin system (Scheff-
er et al., 1990). The decrease of Bcl-2 was slower,
rolonging its expression in time (Bcl-2 was still detected
uring the first week), while Bax expression, although
pregulated, was significantly lower than that of control
rimary human keratinocytes maintained for 3 weeks in differentiation
stain (condensed chromatin) are positive for TUNEL (fragmented DNA).
and apoptotic bodies by DAPI stain, are shown in B.er of p
y DAPI
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389HPV16 E6 ONCOPROTEIN INHIBITS APOPTOSIS50%), consistent with the reduction of apoptosis. These
atterns of changes in protein levels and the differences
bserved between E6A and vector virus infected cultures
ere repeatedly observed in independent infection ex-
eriments (Fig. 8D; and data not shown).
DISCUSSION
In the present study we show that the end process of
uman foreskin keratinocyte in vitro differentiation is cell
eath with characteristics of apoptosis, including chro-
atin condensation and fragmentation, DNA degrada-
ion, and the appearance of cells with hypodiploid DNA
ontent (sub-G1). Apoptosis has been previously ob-
erved in vivo in differentiating keratinocytes (McCall
nd Cohen, 1991; Haake and Polakowska, 1993), and
lthough it is a matter of controversy (Mitra et al., 1997),
FIG. 4t has been suggested that keratinocyte terminal differ-
ntiation and apoptosis proceed along the same path-
ay (Polakowska et al., 1994; Budtz, 1994).
Apoptosis detected in in vitro differentiated keratino-
ytes appears to represent the natural stage of PCD
ssociated with terminal differentiation of skin cells
ather than the response to upset of normal cell physi-
logy or inappropriate cell growth that could result from
levation of calcium levels. This is supported by the facts
hat significant levels of apoptotic cells were detected
nly after prolonged growth in serum–calcium medium
2–3 weeks), after peak levels of involucrin and transglu-
aminase 1 were reached, and these were confined to
he uppermost layers of the stratifying keratinocytes.
The use of retroviral vector to express the epitope-
agged E6 protein of HPV16 allowed us to monitor its
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390 ALFANDARI ET AL.ffect on the different processes occurring during kera-
inocyte in vitro differentiation. Results presented herein
ndicated that E6 expression did not prevent upregula-
FIG. 5. Quantitation of apoptosis in terminally differentiating keratino
n tissue culture slide chambers after being selected in KSFM containi
o differentiation medium. Chambers were stained with DAPI at the ind
otal nuclei (B). At least 900 nuclei were counted for each data point.
TABLE 1
Cell Cycle Distribution of PHK Infected with the Vector or E6A
arrying Virus at Various Time Intervals after Serum–Calcium
witch
Sub G1 G1 S G2/M
xperiment 1
Vector 0 0 34.9 48.3 16.8
3 days 0 64.4 30.4 5.2
18 days 23.9 82.4 17.0 0.5
E6A 0 0 40.8 59.2 0
3 days 0 49.3 40.6 10.1
18 days 0 74 21.5 4.5
xperiment 2
Vector 0 0 30.3 69.7 0
2 days 0 64.3 35.7 0
18 days 8.5 85.6 14.4 0
E6A 0 0 18.3 81.7 0
2 days 0 64.1 35.9 0
18 days 0 88.5 11.5 0ion of differentiation marker proteins and did not affect
ignificantly the decline in cell growth subsequent to
erum–calcium switch. The most prominent difference
bserved between E6 infected keratinocytes and vector
irus infected controls was the reduction in cell stratifi-
ation and cell death. It is possible that both effects are
inked as reduced apoptosis could result from the pre-
ention of cell detachment and stratification. In vivo,
poptotic cells in the epithelium have been observed
ainly in the upper granular layer, and these cells seem
o be at the final stage of differentiation leading to cor-
ification (McCall and Cohen, 1991; Haake and Pola-
owska, 1993; Polakowska et al., 1994). However, com-
itment of keratinocytes to death by apoptosis appears
o be initiated by loss of contact with extracellular matrix
Meredith et al., 1993; Frisch and Francis, 1994; Kikuchi
t al., 1997). Cell attachment or, more importantly, cell
preading induced by integrin ligation to extracellular
atrix proteins such as fibronectin, and the signals gen-
rated by it, appears to be needed to avoid apoptosis
reviewed by Ruoslahti and Reed, 1994; Frisch and Ruo-
lahti, 1997). E6 could possibly activate integrin signaling
athways through its ability to transcriptionally activate
nfected with the E6A or vector virus. Virally infected cells were plated
mg/ml G418. After formation of monolayers (24 h) cells were switched
time points (A). The percentage of apoptotic nuclei was counted per
shown in B are an average of two independent infections.cytes i
ng 100
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391HPV16 E6 ONCOPROTEIN INHIBITS APOPTOSISibronectin gene expression (Shino et al., 1995) or its
bility to form complexes with paxillin (Tong and Howley,
997). Further studies are needed to establish the role of
6 in integrin signaling and the connection to inhibition
f cell stratification and apoptosis in terminally differen-
iating keratinocytes.
E6 function in inhibition of apoptosis could be sepa-
ate from and additional to the ability of E6 to reduce cell
tratification. The precise function of E6 in inhibiting cell
eath of terminally differentiated keratinocytes needs
urther investigation. One possibility is that it is mediated
hrough modulation of p53, a well-known target of E6 and
egulator of cell growth and apoptosis (reviewed by Le-
FIG. 6. Cell-cycle profiles of PHKs infected with the E6A or vector
iruses. Cells were analyzed by FACS prior to and at different intervals
days) after switch to differentiation medium. Apoptosis indicated by
he appearance of cells with low content of DNA (Sub-G1) is detected
nly in the vector virus infected cells after 18 days of growth in
ifferentiation medium.ine, 1997). E6 could inhibit apoptosis of PHKs by pre-
enting the accumulation of p53. Although E6 expression
trongly decreased p53 levels in PHKs, several observa-
ions raise doubts about the significance of this reduc-
ion in E6-mediated inhibition of apoptosis in terminally
ifferentiating PHKs. First, the data presented herein,
nd previous findings in human and mouse keratino-
ytes (Woodworth et al., 1993; Missero et al., 1995) show
hat p53 levels normally decrease, rather than increase,
uring terminal differentiation and onset of apoptosis.
econd, our previous data indicate a lack of ability of a
uman dominant mutant p53 and human MDM-2 to func-
ionally replace E6 in the induction of calcium- and se-
um-resistant keratinocyte colonies (Sherman et al.,
997). Third, preliminary results obtained from functional
nalyses of epitope-tagged E6 mutants indicate differ-
nces in the activities of some mutants between the PHK
olony assay and the p53 in vivo degradation assay in
aos cells. For example, deletion mutant D128–132,
hich exhibited moderate activity in p53 degradation in
ivo, was completely defective in its ability to induce
ifferentiation-resistant colonies in PHKs.
HPV E6 proteins were previously shown to protect
ells from apoptosis induced by different triggers in p53-
ependent and -independent pathways. Inhibition of p53-
ependent apoptosis was demonstrated in human fibro-
lasts induced to die by the expression of HPV16 E7
White et al., 1994) and UV irradiation (Thomas et al.,
996). E6 was also shown to protect mouse cells that
ack p53 (Steller et al., 1996) and human keratinocytes
hat carry mutated alleles of p53 (Shnitman Magal et al.,
998) from apoptosis induced by DNA damage. In trans-
enic mouse models, E6 protected lens fiber cells from
poptosis induced during the natural lens fiber cell dif-
erentiation by both p53-dependent and p53-independent
athways (Pan and Griep, 1995).
An important class of proteins suggested to play an
ntegral role in regulating PCD is the pro- and anti-
poptotic members of the Bcl-2 gene family (reviewed by
ang and Korsmeyer, 1996; Kelekar and Thompson,
998). These proteins serve as common targets of viral
ncoproteins that promote cell survival and inhibit apop-
osis (reviewed by Teodoro and Branton, 1997). In squa-
ous epithelia, levels and topographic distribution of a
umber of these proteins were shown to be related to
tages of differentiation (Hockenbery et al., 1991; Lu et
l., 1993; Jordan et al., 1996; Maruoka et al., 1997). Bcl-2,
suppressor protein of apoptosis, is expressed exclu-
ively in the undifferentiated basal layer of the epithelium
Hockenbery et al., 1991; Lu et al., 1993; Polakowska et
l., 1994; Jordan et al., 1996) while expression of Bax, a
ro-apoptotic protein, is increased in the suprabasal
ayers (Jordan et al., 1996; Maruoka et al., 1997). In
greement with the in vivo findings, a decrease in Bcl-2
nd an increase in Bax levels were detected during
erum–calcium differentiation of cultured PHKs. Time
ourse analyses indicated that the decrease in Bcl-2
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392 ALFANDARI ET AL.evels preceded the elevation of Bax and coincided with
he upregulation of transglutaminase 1, an early differen-
iation protein. Downregulation of Bcl-2 seems to repre-
ent an early event of keratinocyte differentiation, while
ells commit to differentiation and prior to the activation
f the cell death program. Downregulation of Bcl-2 ex-
ression was shown to enhance the progression of epi-
ermal differentiation and it was suggested that basal to
pinous transition by Bcl-2 may be achieved via the
ontrol of the apoptotic machinery (Marthinuss et al.,
995). The increase in Bax protein levels, however, was
emporally linked to the appearance of morphological
igns of cell demise; therefore upregulation of Bax may
e considered as a marker for the terminal stage of
oreskin keratinocyte differentiation, consistent with pre-
ious observations in oral keratinocytes (Maruoka et al.,
997). In cells infected with the E6A virus, prolonged
FIG. 7. Time-related changes in the expression of growth/apoptosis c
nd immunoblotted as described in the legend to Fig. 1. Strips of the s
A). Levels of the proteins quantified by densitometric scanning are sh
FIG. 8. Time-related changes in the expression of apoptosis control p
nalyses of cell lysates obtained from two independent infections ar
eparate gel for expression of differentiation marker proteins (Fig. 2A)
n B. The collated results of protein levels of Bcl-2, Bax, and p53 after
. Protein levels at time points in which maximal increase (Bax) or dec
ompared to their matched-day E6A cultures. Levels of p53 in the E6A
rom three independent experiments with standard deviations are shoeriods of Bcl-2 expression and reduced elevation of Bax
evels were observed. E6 could possibly modulate Bcl-2
nd Bax levels by direct interaction, thereby stabilizing
nd destabilizing these proteins, respectively. Although
6 lacks the Bcl-2 homology domains (Yang and Kors-
eyer, 1996; Kelekar and Thompson, 1998), which are
hought to be important for complex formation among
amily members and functional homologs of Bcl-2, such
s E1 B 19K of adenovirus that binds to Bax (Han et al.,
996) and the Kaposi’s sarcoma-associated herpes virus
Sarid et al., 1997), Bcl-2 was shown to interact also with
onfamily proteins such as R-ras (Fernandez-Sarabia
nd Bischoff, 1993).
Of interest in this respect are recent studies showing
hat HPV18 E6 protein can inhibit Bak-induced apoptosis
nd that this is mediated by an interaction between E6
nd Bak proteins, resulting in the degradation of Bak in
roteins following serum–calcium switch. Cell lysates were fractionated
lot were subsequently reacted with antibodies to p53, Bcl-2, and Bax
B.
following serum–calcium switch in virally infected PHKs. Western blot
n in A and C, respectively. Lysates shown in A were analyzed on a
x. Levels of the proteins shown in A (relative to actin) are presented
calcium switch relative to their levels before switch (%) are shown in
Bcl-2 and p53) was detected in the vector virus infected cultures were
s were undetectable at that time and could not be measured. Resultsontrol p
ame b
own inroteins
e show
and Ba
serum–
rease (
culture
wn.
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394 ALFANDARI ET AL.ivo (Thomas and Banks, 1998). Our preliminary data
ndicate that Bak protein levels in PHKs are upregulated
ubsequent to serum–calcium switch in a temporal pat-
ern similar to that of Bax. Studies are in progress to
etermine whether apoptosis of PHKs is associated with
hanges in the expression of additional Bcl-2 members
nd whether E6 modulates their level.
The present study shows that E6 acts as a survival
nti-apoptotic factor in a cellular setting that is relevant
or the viral life cycle. The productive life cycle of human
apillomavirus is linked to the differentiation state of
quamous keratinocytes. The target cells for HPV infec-
ion are basal keratinocytes, but viral DNA replication
nd synthesis of viral capsid proteins can occur only in
he terminally differentiated layers. HPVs have evolved
ifferent strategies to allow the continuation of viral rep-
ication without blocking the process of keratinocyte dif-
erentiation. HPV16 E7 was previously demonstrated to
verride growth arrest signals during keratinocyte termi-
al differentiation (Demers et al., 1996; Jones et al., 1997;
ei et al., 1998), thus likely allowing for viral DNA repli-
ation to continue in suprabasal keratinocytes (Blanton
t al., 1992; Cheng et al., 1995; Jian et al., 1998). In the
resent study we show that HPVs apply a second strat-
gy to allow viral reproduction to proceed, by preventing
he cell death of fully differentiated keratinocytes, thereby
ontributing the creation of the cellular environment in
hich HPV late gene expression and assembly can oc-
ur. On the other hand, the ability of E6 to delay differ-
ntiation and to extend the survival of epithelial cells may
ave a role in the early stages of oncogenesis by in-
reasing the pool of live cells sensitive to the immortal-
zing activity of E7.
MATERIALS AND METHODS
reparation of primary human keratinocytes,
etroviral infection, and induction of differentiation
Primary human keratinocytes were isolated from
eonatal foreskins obtained from circumcisions and
eeded onto J-irradiated 3T3 J2 cells as previously
escribed (Schlegel et al., 1988). Cells were subse-
uently passaged and maintained in serum-free kera-
inocyte growth medium (Gibco BRL, Gaithersburg,
D), supplemented with epidermal growth factor (5
g/ml) and bovine pituitary extract (BPE) (50 mg/ml).
ifferentiation was induced by switching keratinocyte
onolayers grown in KSFM to high-calcium- and high-
erum-containing medium consisting of Dulbecco’s
odified Eagle’s medium (Gibco BRL), supplemented
ith 10% fetal bovine serum and 1 mg/ml hydrocorti-
one (Schlegel et al., 1988).
Packaging cell lines (PA317) producing recombinant
etroviruses, LXSN and E6 tagged with the epitope AU1
E6A), retroviral infection of human keratinocytes, and
etection of retroviral gene expression were previously
escribed (Pei et al., 1998; Shnitman Magal et al., 1998).or differentiation studies, PHKs in the first or second
assage were infected at 50% confluency in 25-cm2
lasks at multiplicity of infection of 2–5 infectious parti-
les per cell and then selected for 1 day with G418
Geneticin; 100 mg/ml) in KSFM. After further growth in
eneticin-free KSFM for 4–5 days, infected cells were
assaged into 75-cm2 flasks. Monolayers formed after
rowth in KSFM (1 week) were switched to differentiation
edium. Cultures were maintained in differentiation me-
ium for 3–4 weeks with medium changes as described
Sherman and Schlegel, 1996). Cells were harvested at
he indicated time points. For immunofluorescence stain-
ng and apoptosis analyses, infected cells were plated
nto slide chambers at a density of 4 3 104 cells per
ell.
erminal deoxy transferase-mediated dUTP biotin nick
nd-labeling analysis and 49,6-diamidine-2-
henylindole-dihydrochloride stain
Adherent and detached cells were collected and fixed
n 4% paraformaldehyde for 20 min at room temperature
RT). After three washes in PBS, cells were pelleted on
oly-L-lysine-coated glass slides and then incubated in
BS containing 0.2% Triton for 10 min at RT. Next, slides
ere rinsed and cells incubated with 50 ml of terminal
eoxynucleotidyl transferase (TdT) buffer [30 mM Tris
pH 7.2), 140 mM sodium cacodylate, 1 mM cobalt chlo-
ide] for 10 min followed by addition of 50 ml of CoCl2
eaction mix (Boehringer Mannheim, Mannheim, Ger-
any) containing 2 nmol biotin-16–dUTP and 25 U TdT
nzyme (Boehringer Mannheim) and further incubation
or 1 h at 37°C. Slides were then blocked with 2% BSA for
0 min, rinsed in PBS, and incubated with ExtrAvidin-
ITC (BioMakor, Rehovot, Israel) at a 1:50 dilution for 30
in at 37°C. After being rinsed with PBS, cells were
ounterstained with DAPI (Boehringer Mannheim) at 0.1
g/ml in PBS for 10 min at 37°C. After staining, slides
ere rinsed in PBS and mounted on coverslips. For
taining in monolayers, cells were grown in slide cham-
ers, fixed, and stained as described above.
low-cytometric analysis of DNA content
Preparation of cells collected for flow-cytometric anal-
sis was according to the method of Darzynkiewicz et al.
1992). Briefly, cells collected from monolayers and su-
ernatants (106 to 107 cells) were combined and fixed
ith 70% ethanol for 30 min on ice. After centrifugation
ells were rehydrated in PBS, centrifuged, and resus-
ended in 0.5 ml PBS. To facilitate removal of low-mo-
ecular-weight DNA from apoptotic cells, 0.5 ml of extrac-
ion buffer containing 192 parts of 0.2 M Na2HPO4 and 8
arts of 0.1 M citric acid (pH 7.8) was added and samples
ere incubated at RT for 30 min. Cells were then pelleted
nd stained for 30 min at RT with 20 mg/ml propidium
odide (Sigma) in the presence of 200 mg/ml DNase-free
Nase A. Flow-cytometric analysis of 5 3 103 cells was
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395HPV16 E6 ONCOPROTEIN INHIBITS APOPTOSISarried out in a fluorescence-activated cell sorter (FAC-
can; Becton Dickinson, Mountain view, CA) and the
ercentage of cells in the G1, S, and G2/M phases of the
ell cycle was determined using the CellQuest program
f Becton Dickinson. Data were analyzed with the MUL-
ICYCLE program (Phoenix Flow Systems, San Diego,
A). The sub-G1 peak values represent the percentage of
poptotic cells relative to the total number of cells dis-
ributed in the G1, S, and G2/M phases (100%).
mmunoblotting analysis of protein abundance
Preparation of cell lysates in modified RIPA buffer,
lectrophoresis on polyacrylamide gels, and transfer to
itrocellulose membranes were previously described
Sherman and Schlegel, 1996; Shnitman Magal et al.,
998). Filters were cut into strips and reacted with the
pecific antibodies. Primary antibodies used were as
ollows: the p53 DO-1 monoclonal antibody (Mab) (SC-
26) and Bax rabbit polyclonal antibody (SC-493), both
rom Santa Cruz Biotechnology (Santa Cruz, CA); the
uman Bcl-2 Mab (M 0887, DAKO A/S, Denmark), the
uman cytokeratin 19 Mab (NCL-CK19) (Novacostra Lab-
ratories, Ltd., Newcastle-upon Tyne, UK), the human
nvolucrin Mab (19018, Sigma Israel Chemicals Ltd., Re-
ovot), the human transglutaminase Mab BC-1 (a gift
rom R. H. Rice, University of California, Davis, CA), and
he human actin Mab (1378996, Boehringer Mannheim).
roteins were visualized by enhanced chemilumines-
ence (Amersham, Arlington Heights, IL) using peroxi-
ase-conjugated anti-mouse IgG (115-035-003 Jackson
mmunoResearch Laboratories, Inc.) or protein A–peroxi-
ase (NA 9120) (Amersham) according to the manufac-
urer’s instructions. Protein amounts were determined by
ensitometric scanning (Dinco and Rhenium Biological
mmaging System BIS 202, Israel) and normalized rela-
ive to the amount of b-actin protein. In some cases the
ame blot was stripped and subsequently probed with
ifferent antibodies.
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